44 results on '"Cutter, David J"'
Search Results
2. Cardiovascular disease incidence rates: a study using routinely collected health data
3. Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
4. Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection
5. Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry
6. Cardiovascular and Pulmonary Late Effects
7. Cardiac Structure Doses in Women Irradiated for Breast Cancer in the Past and Their Use in Epidemiological Studies
8. Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?
9. Radiation-related cardiovascular disease following cancer therapy
10. Authors’ reply to Oke and Welch
11. Cardiovascular and Pulmonary Late Effects
12. 1688: Exposure of breast tissue in modern radiotherapy for lymphoma: a systematic review
13. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee
14. Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review
15. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
16. A cardiac contouring atlas for radiotherapy
17. Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials
18. Cardiovascular and Pulmonary Late Effects
19. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma
20. Simple Method to Estimate Mean Heart Dose From Hodgkin Lymphoma Radiation Therapy According to Simulation X-Rays
21. Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma
22. Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives
23. Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study)
24. Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
25. Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma
26. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)
27. Cardiovascular and Pulmonary Late Effects
28. Radiation-Related Heart Disease: Current Knowledge and Future Prospects
29. Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline.
30. Limited‐stage diffuse large B‐cell lymphoma: current management and challenges
31. Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction
32. Risks of Heart Disease after Radiotherapy
33. Risk of cerebrovascular disease among 13 457 five‐year survivors of childhood cancer: A population‐based cohort study
34. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age
35. Forebrain Connectivity of the Prefrontal Cortex in the Marmoset Monkey (Callithrix jacchus): An Anterograde and Retrograde Tract-Tracing Study
36. Risk of cerebrovascular disease among 13 457 five‐year survivors of childhood cancer: A population‐based cohort study.
37. Long-term hospitalisation rates among 5-year survivors of Hodgkin Lymphoma in adolescence or young adulthood - A nationwide cohort study
38. Conflating case fatality with mortality.
39. Reply to D. Vordermark and T. Pelz and R. Mazzola et al
40. Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
41. Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.
42. Breast cancer mortality in 500 000 women with early invasive breast cancer in England, 1993-2015: population based observational cohort study
43. Risk of valvular heart disease after treatment for Hodgkin lymphoma.
44. Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.